Overview
Test order codeHelpLaboratory's order or catalog code for the test (used in the order requisition form).: COVID
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA Detection, PCR, Varies (SARS Coronavirus 2 PCR Detect, V)
This is a clinical microbial test intended for HelpPurposes or indications for the test. Lab-provided.: Diagnosis, Microbe identification
Loading data ......
Click Indication tab for more information.
CPT Code U0003. Contact Customer Service (https://www.mayocliniclabs.com/customer-service/contacts.html)
Order URL HelpLink to the laboratory webpage with information about how to order this test. Please note that clicking on this link will open a new tab in your internet browser.: https://www.mayocliniclabs.com/order-tests/account-setup.html
Specimen source
Bronchoalveolar lavage
Nasal swab
Nasopharyngeal (NP) swab
Nasopharyngeal washes
Oropharyngeal (OP) swab
Sputum
Sample requirements
Details of sample collection are described at https://www.mayocliniclabs.com/test-catalog/Specimen/608825
Turnaround time
Analytic Time: Same day/1 day
Maximum Laboratory Time: 3 days
Specimen Retention Time: 4 days
- Molecular Genetics
- RRNA analysis
- RT-PCR
- Cobas® 6800 / 8800 System
Summary of what is tested
Loading data ......
Click Methodology tab for more
information.
Not provided
Not provided
Comments about the test interpretation (e.g. clinical implication of test results)
A "Detected" result indicates that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA is present and suggests the diagnosis of coronavirus disease 2019 (COVID-19). Test result should always be considered in the context of patient's clinical history, physical examination, and epidemiologic exposures when making the final diagnosis. An "Undetected" result indicates that SARS-CoV-2 is not present in the patient's specimen. However, this result may be influenced by the stage of the infection, quality, and type of the specimen collected for testing. Result should be correlated with patient’s history and clinical presentation. An "Indeterminate" result suggests that the patient may be infected with a variant SARS-CoV-2 or SARS-related coronavirus. Additional testing with an alternative molecular method may be considered if the patient does not have signs or symptoms of COVID-19. An "Inconclusive" result indicates that the presence or absence of SARS-CoV-2 RNA in the specimen could not be determined with certainty after repeat testing in the laboratory, possibly due to RT-PCR inhibition. Submission of a new specimen for testing is recommended. Sequence analyses have predicted that this assay will detect the circulating variants reported by the U.S. Centers for Disease Control and Prevention (www.cdc.gov/coronavirus/2019-ncov/more/science-and-research/scientific-brief-emerging-variants.html), such as the United Kingdom (B.1.1.7), South Africa (B.1.351), and Brazil (P.1) variants.